April 30, 2015
Orexo divests subsidiary Kibion
Media
April 29, 2015
BONESUPPORT Announces CE-Mark of CERAMENT™|V, the First Injectable Vancomycin Eluting Bone Substitute in the Management of Osteomyelitis
April 27, 2015
Aerocrine AB responds to recent speculation in the market
April 24, 2015
HealthCap awarded SVCA’s Deal of the Year
April 23, 2015
RESULTS OF PHASE 1 STUDY OF BETALUTIN™ IN PATIENTS WITH NON-HODGKIN LYMPHOMA TO BE PRESENTED AT THE INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMA
April 23, 2015
Interim report January-March 2015
April 22, 2015
Aerocrine: Sales start of NIOX VERO® in Japan
April 22, 2015
New 24-week clinical study strengthens the evidence of the therapeutic value of Zubsolv for maintenance treatment of opioid dependence
April 22, 2015
Nordic Nanovector ASA – Stabilisation notice and exercise of over-allotment option, total gross proceeds from IPO increase to NOK 575 million
April 22, 2015
Orexo to present at 2015 Nordic Life Sciences Conference